Supplemental Complement Component C9 Enhances the Capacity of Neonatal Serum to Kill Multiple Isolates of Pathogenic Escherichia Coli

Pediatric Research - United States
doi 10.1203/00006450-199404000-00002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Administration of Complement Component C9 Enhances the Survival of Neonatal Rats With Escherichia Coli Sepsis1

Pediatric Research
Child HealthPediatricsPerinatology
1997English

PRC Contributes to Escherichia Coli Evasion of Classical Complement-Mediated Serum Killing

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2012English

TaqI Polymorphism at the Human Complement Component C9 Gene

Nucleic Acids Research
Genetics
1990English

Molecular Cloning, Sequence Analysis and Expression of Ayu Complement Component C9 Gene

Zoological Research
2013English

SLE-like and Sicca Symptoms in Late Component (C9) Complement Deficiency.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1987English

First Detection of Pathogenic Escherichia Coli Isolates Associated With Donkey Foals' Diarrhea in Northern China

2020English

Human Serum Complement Requirements for Bacterial Killing and Protoplast Lysis of Escherichia Coli ML308 225

Microbiology
Microbiology
1981English

Escherichia Coli and Neonatal Disease of Calves

Bacteriological Reviews
1965English

Response of Extraintestinal Pathogenic Escherichia Coli to Human Serum Reveals a Protective Role for RCS-Regulated Exopolysaccharide Colanic Acid

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy